Overcoming transport barriers to immunotherapy

Overcoming transport barriers to immunotherapy
复制标题

克服免疫治疗的运输障碍

DOI:
--
复制
发表时间:
2021
影响因子:
5.4
通讯作者:
M. Swartz
M. Swartz
中科院分区:
医学2区
文献类型:
--
作者:
Shann S. Yu;J. Hubbell;M. Swartz

文献摘要

参考文献

被引文献

相似文献

免疫疗法旨在通过调节免疫细胞的活性来治疗疾病。在此,我们探讨解剖结构和微生理学如何对免疫疗法在病变部位的递送和滞留造成运输障碍,并总结近期通过利用免疫生物学来设计分子和细胞工程方法以克服这些障碍的进展。针对这些疾病创造有影响力且实用的解决方案需要病理学家、临床医生、免疫学家、生物物理学家、免疫工程师等各方专业知识的整合。
Immunotherapies are designed to treat disease by modulating the activity of immune cells. Here, we consider how anatomy and microphysiology create transport barriers to immunotherapeutic delivery and retention at diseased sites, and summarize recent developments to overcome these barriers by exploiting immunobiology to engineer molecular and cellular engineering approaches. Creating impactful and practical solutions across these diseases requires the integration of the collective expertise of pathologists, clinicians, immunologists, biophysicists, immunoengineers, and more.
DOI: 10.1016/j.jconrel.2006.01.006
发表时间: 2006-05-01
影响因子: 10.8
作者:
Reddy, ST;Rehor, A;Swartz, MA
通讯作者: Swartz, MA
DOI: 10.1016/j.jconrel.2015.09.063
发表时间: 2015-12-10
期刊: Journal of controlled release : official journal of the Controlled Release Society
影响因子: --
作者:
Leleux J;Atalis A;Roy K
通讯作者: Roy K
DOI: 10.1016/j.jconrel.2014.03.050
发表时间: 2014-09-28
期刊: Journal of controlled release : official journal of the Controlled Release Society
影响因子: --
作者:
Anselmo AC;Mitragotri S
通讯作者: Mitragotri S
DOI: 10.1016/j.trecan.2018.02.010
发表时间: 2018-04
期刊: Trends in cancer
影响因子: 18.4
作者:
Stylianopoulos T;Munn LL;Jain RK
通讯作者: Jain RK
DOI: 10.1126/science.aat7554
发表时间: 2019-01-25
期刊: SCIENCE
影响因子: 56.9
作者:
Costa Jordao, Marta Joana;Sankowski, Roman;Prinz, Marco
通讯作者: Prinz, Marco